JP2774882B2 - Whitening and anti-aging cosmetics - Google Patents
Whitening and anti-aging cosmeticsInfo
- Publication number
- JP2774882B2 JP2774882B2 JP3197490A JP19749091A JP2774882B2 JP 2774882 B2 JP2774882 B2 JP 2774882B2 JP 3197490 A JP3197490 A JP 3197490A JP 19749091 A JP19749091 A JP 19749091A JP 2774882 B2 JP2774882 B2 JP 2774882B2
- Authority
- JP
- Japan
- Prior art keywords
- whitening
- water
- skin
- extract
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 13
- 230000002087 whitening effect Effects 0.000 title claims description 10
- 230000003712 anti-aging effect Effects 0.000 title claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 244000086363 Pterocarpus indicus Species 0.000 claims description 2
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims description 2
- 244000133098 Echinacea angustifolia Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000014134 echinacea Nutrition 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 239000008057 potassium phosphate buffer Substances 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 244000307697 Agrimonia eupatoria Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- -1 Polyoxyethylene Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000000125 common agrimony Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000016626 Agrimonia eupatoria Nutrition 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は美白作用を有し且つ皮膚
を滑らかにし、若々しい皮膚を保つ美白及び老化防止化
粧料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening and anti-aging cosmetic which has a whitening effect, smoothes the skin and keeps youthful skin.
【0002】[0002]
【従来の技術】キンミズヒキ属は双子葉植物網、離弁花
亜網、ばら科に属する。日本ではキンミズヒキ(Agrimo
nia eupatoria)が本州、四国、九州、琉球に自生し、
山野や道ばたにはえる多年草である。日本以外では朝
鮮、台湾、シベリア、ヒマラヤの暖帯から温帯に分布し
ている。BACKGROUND OF THE INVENTION agrimony genus dicots network, Hanareben flower Amo, belongs to the rose family. In Japan, Agrimony (Agrimo
nia eupatoria) grows natively in Honshu, Shikoku, Kyushu and Ryukyu,
It is a perennial plant that can be found on mountains and roadsides. Outside Japan, it is distributed in the warm to temperate zones of Korea, Taiwan, Siberia, and the Himalayas.
【0003】この草は仙鶴草と称し、その全草が利用さ
れている。その目的は、止血、止瀉、消炎、強壮薬とし
て、また吐血、血便、血尿、崩漏帯下、赤白痢疾等の諸
出血症状に利用されている。しかし、化粧料としては特
開平1−313414号公報で頭部化粧料として、特開
昭60−184024号公報で殺菌性組成物として利用
されているにすぎない。[0003] This grass is called Senkaku-so and the whole grass is used. It is used for hemostasis, antidiarrhea, antiphlogistic, tonic, and for various bleeding symptoms such as hematemesis, bloody stool, hematuria, cramps, and dysentery. However, as a cosmetic, it is only used as a head cosmetic in JP-A-1-313414 and as a bactericidal composition in JP-A-60-184024.
【0004】[0004]
【発明が解決しようとする課題】本発明の目的は、入手
が容易な原料から、皮膚に適用して安全であると共に皮
膚を滑らかにし、美白作用があり、若々しい皮膚を保つ
美白及び老化防止化粧料を提供することにある。SUMMARY OF THE INVENTION The object of the present invention is to provide a skin-whitening and aging preservation of youthful skin from a readily available raw material, which is safe and smooth when applied to the skin, has a skin-whitening effect, and keeps youthful. An object of the present invention is to provide a preventive cosmetic.
【0005】[0005]
【課題を解決するための手段】本発明者らは、入手が容
易である植物の抽出物を数多く試験した結果、仙鶴草が
その美白作用、皮膚老化防止作用等の点で化粧料として
非常に有効であることを見いだし本発明を完成した。す
なわち本発明は、ばら科キンミズヒキ属の全草の溶媒抽
出物を含む美白及び老化防止化粧料である。The inventors of the present invention have conducted tests on a number of plant extracts that are easily available, and as a result, it has been found that Sengakurusa is very useful as a cosmetic in terms of its whitening effect and skin aging prevention effect. The present invention was found to be effective, and the present invention was completed. That is, the present invention is a whitening and anti-aging cosmetic comprising a solvent extract of a whole plant belonging to the genus Rosewood.
【0006】キンミズヒキ属は、すでに生薬として、そ
の全草を乾燥したものが医薬品原料として販売されてい
るし、且つ日本の山野で容易に自生したものを採取でき
るのである。化粧品原料とするには、これを親水性有機
溶媒で抽出するが、一般的にはエタノール、さらにはメ
タノール、ブタノール、アセトン、またはこれらの混合
物で抽出する。これらの有機溶媒の一部を水に置き換え
ることも可能である。水の量は親水性有機溶媒の種類に
よって大きく異なるが、エタノールの場合50%以上水
を加えた溶媒で抽出すると美白成分が減少する。なお、
水のみ或いはエタノールの場合、水が50%以上でも美
白成分は減少し、このような抽出方法をとる意味がない
が、活性酸素抑制効果には影響なく、目的によってはこ
のような抽出方法もまた選択できる。The genus Agaricus is already sold as a crude drug, its dried whole plant is sold as a raw material for a medicinal product, and it is possible to easily collect the native one in Yamano, Japan. To make a cosmetic raw material, it is extracted with a hydrophilic organic solvent, but is generally extracted with ethanol, and further with methanol, butanol, acetone, or a mixture thereof. It is also possible to replace some of these organic solvents with water. Although the amount of water varies greatly depending on the type of hydrophilic organic solvent, in the case of ethanol, extraction with a solvent containing 50% or more of water reduces the whitening component. In addition,
In the case of water alone or ethanol, even if the water content is 50% or more, the whitening component is reduced, and there is no point in taking such an extraction method. You can choose.
【0007】この抽出物を、他の化粧品原料例えばスク
ワラン、ホホバ油等の液状油、ミツロウ、セチルアルコ
ール等の固体油、各種の活性剤、グリセリン、1,3ブ
チレングリコール等の保湿剤や各種薬剤等を添加して、
さまざまな剤形の化粧料を調製することができる。例え
ばローション、クリーム、乳液、パック等で目的に応じ
て利用形態を考えればよい。This extract is used as a raw material for other cosmetics such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3-butylene glycol, and various chemicals. Add
Various dosage forms of cosmetics can be prepared. For example, a use form may be considered depending on the purpose, such as a lotion, a cream, an emulsion, a pack, and the like.
【0008】本発明の抽出物の使用濃度としては、利用
する目的や他の配合原料によって影響を受けることは当
然であり、特に限定はないが通常0.0001〜5%で
用いるのが普通である。The use concentration of the extract of the present invention is naturally affected by the purpose of use and other ingredients, and is not particularly limited, but is usually 0.0001 to 5%. is there.
【0009】[0009]
【実施例】以下に実施例により、本発明を更に具体的に
説明するが、本発明は、この実施例によって何等限定さ
れるものではない。先づ実施例、比較例で使用した抽出
物(乾燥固形物)の製造例について説明する。EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the present invention. First, production examples of the extract (dry solid) used in Examples and Comparative Examples will be described.
【0010】(製造例1)乾燥した仙鶴草20gにメタ
ノール200mlを加えて、3時間還流冷却する。これを
濾過後、凍結乾燥した。収量は1.98gであった。(Production Example 1) 200 ml of methanol was added to 20 g of dried cranes and the mixture was refluxed and cooled for 3 hours. This was filtered and freeze-dried. The yield was 1.98 g.
【0011】(製造例2)乾燥した仙鶴草10gにエタ
ノール300mlを加えて、ソックスレー抽出器にかけて
抽出した。抽出液を凍結乾燥した。収量は1.87gで
あった。(Production Example 2) To 10 g of dried cranes, 300 ml of ethanol was added and extracted with a Soxhlet extractor. The extract was freeze-dried. The yield was 1.87 g.
【0012】(実施例1) ローション (重量部) 製造例1の仙鶴草メタノール抽出物(乾燥物) 1.0 エタノール 80.0 精製水 19.0 100.0(Example 1) Lotion (parts by weight) Methanol extract of Sengaku moss from Production Example 1 (dry product) 1.0 Ethanol 80.0 Purified water19.0 100.0
【0013】(実施例2) クリーム (重量部) A. スクワラン 20.0 ホホバ油 5.0 ミツロウ 5.0 セトステアリルアルコール 2.0 グリセリンモノステアレート 1.0 ソルビタンモノステアレート 2.0 製造例2の仙鶴草エタノール抽出物(乾燥物) 1.0 36.0 B. 精製水 55.9 ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0 ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0 グリセリン 5.0 パラオキシ安息香酸メチル 0.1 64.0 AとBとをそれぞれ計量し、70℃まで加温し、BにA
を攪拌しつつ徐々に加えたのち、ゆっくり攪拌しつつ3
0℃まで冷却した。(Example 2) Cream (parts by weight) A. Squalane 20.0 Jojoba oil 5.0 Beeswax 5.0 Cetostearyl alcohol 2.0 Glycerin monostearate 1.0 Sorbitan monostearate 2.0 Ethanol extract of Sengaku grass of Production Example 2 (dry product)1.0 36.0 B.R. Purified water 55.9 Polyoxyethylene (20E.O.) sorbitan monostearate 2.0 Polyoxyethylene (60E.O.) hydrogenated castor oil 1.0 Glycerin 5.0 Methyl paraoxybenzoate0.1 64.0 A and B were respectively weighed, heated to 70 ° C., and A was added to B.
Is slowly added with stirring, and then slowly stirred.
Cooled to 0 ° C.
【0014】(比較例1)前記実施例1の抽出乾燥物を
水に替えたものを比較例1とする。Comparative Example 1 Comparative Example 1 was obtained by replacing the dried extract of Example 1 with water.
【0015】(比較例2)前記実施例2の抽出乾燥物を
水に替えB成分としたものを比較例2とする。Comparative Example 2 Comparative Example 2 was obtained by replacing the dried extract of Example 2 with water and using the B component.
【0016】評価方法としては、前記製造例2の抽出乾
燥物の1.0重量%エタノール溶液について、チロシナ
ーゼ活性阻害率の測定及び活性酸素抑制効果の測定及び
実施例1,2、比較例1,2のローション、クリームに
ついて、パネルによる官能検査によって評価した。The evaluation was carried out by measuring the tyrosinase activity inhibition rate and the effect of inhibiting active oxygen in Examples 1 and 2 and Comparative Examples 1 and 2 for a 1.0 wt% ethanol solution of the dried extract of Production Example 2. The lotion and cream No. 2 were evaluated by a panel sensory test.
【0017】(チロシナーゼ活性阻害率) マックルバルン(Mcllvaln)緩衝液0.9ml、1.66m
Mチロシン(Tyrosine)溶液1.0ml、前記製造例1又
は2の抽出乾燥物をエタノールに溶解させ、水を加えた
後、エバポレータでエタノールを除去した後、0.1重
量(乾燥物)/容量%に調製した液(試料液)1.0ml
をスクリューバイアルにとり、37℃恒温水槽中で5分
以上加温した。チロシナーゼ溶液(Sigma社製、マッシ
ュルーム由来、914ユニット/ml)0.1mlを加え、
37℃恒温水槽中で保温し、10分後に475nmで吸光
度を測定した。対照として、上記試料液の替りに純水を
加え、同様に測定した。 (計算式) チロシナーゼ活性阻害率(%)={B−(A−P)}/B×100 但し、A:試料検体の吸光度 B:対照の吸光度 P:試料検体の着色による吸光度(3倍希釈) 結果を表1に示す。ただし最終濃度は、この表の濃度の
1/3である。 (Tyrosinase activity inhibition rate) Mcllvaln buffer 0.9 ml, 1.66 m
After dissolving 1.0 ml of the M tyrosine solution and the extracted and dried product of Production Example 1 or 2 in ethanol, adding water, and removing the ethanol with an evaporator, 0.1 weight (dry product) / volume 1.0% liquid (sample liquid)
Was placed in a screw vial and heated in a thermostat bath at 37 ° C. for 5 minutes or more. 0.1 ml of tyrosinase solution (manufactured by Sigma, from mushrooms, 914 units / ml) was added,
The temperature was kept in a constant temperature water bath at 37 ° C., and the absorbance was measured at 475 nm after 10 minutes. As a control, pure water was added instead of the sample solution, and the measurement was performed in the same manner. (Calculation formula) Tyrosinase activity inhibition rate (%) = {B− (AP)} / B × 100 where A: absorbance of sample specimen B: absorbance of control P: absorbance of sample specimen by coloring (3 times dilution) The results are shown in Table 1. However, the final concentration is
1/3.
【0018】[0018]
【表1】 [Table 1]
【0019】(活性酸素抑制濃度)大気中には21%の
酸素があり、これがないと生物(嫌気性のものを除く)
は存在しえない。しかし、酸素は紫外線や酵素等の影響
を受けて活性酸素になる。活性酸素は脂肪酸を酸化し過
酸化物を生成させる。生体の生体膜のリン脂質も酸化さ
せ、障害を与える。且つ、生成した過酸化物と活性酸素
はDNAに損傷を与え、老化を促進すると言われてい
る。また、チロシンからメラニンを作る機構にも影響を
与え皮膚の黒化にも関与している。この活性酸素を抑制
することは皮膚にとって重要な、言い換えれば化粧料に
求められる重要な要素の一つである。活性酸素を抑制す
る効果を測定する方法は各種あるが、今回以下の方法を
利用した。 ph7.8,50mM リン酸カリウム緩衝液(1.3mM DETAPAC含有) 133ml 40 unit/ml カタラーゼの上記のリン酸カリウム緩衝液 5ml 2mM ニトロブルーテトラゾリウムの上記のリン酸カリウム緩衝液 5ml 1.8mM キサンチンの上記のリン酸カリウム緩衝液 17ml 160ml 上記の試薬の混合物を2.4ml、前記製造例1又は2の
抽出液の凍結乾燥物をエタノールに溶解させ、水を加え
た後エバポレータでエタノールを除去した後、0.1重
量(乾燥物)/容量%に調整した液(検体)を0.3ml
加えて、キサンチンオキシダーゼ(予め検体を水とし、
実験するとき、吸光度が1分当たり0.02前後上昇す
るように上記のリン酸カリウム緩衝液で調整しておく)
液を0.3ml加えて直ちに吸光度(560nm)を測定す
る。 (測定は2分位し、直線性を確認する。) (計算式) 阻害率=(A−B)/A×100 A:検体を水としたときの1分当たりの吸光度の変化 B:検体の1分当たりの吸光度の変化 50%阻害濃度に換算した結果を表2に示す。ただし最
終濃度は、この表の 濃度の1/9である。 (Active Oxygen Suppression Concentration) There is 21% oxygen in the atmosphere, and without it, organisms (except anaerobic ones)
Cannot exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids to form peroxides. Phospholipids in biological membranes of living organisms also oxidize and cause damage. Moreover, it is said that the generated peroxide and active oxygen damage DNA and promote aging. It also affects the mechanism of melanin production from tyrosine and is involved in skin darkening. Suppressing this active oxygen is important for the skin, in other words, one of the important factors required for cosmetics. There are various methods for measuring the effect of suppressing active oxygen, and the following method was used in this case. ph7.8,50mM potassium phosphate buffer (1.3mM DETAPAC containing) 133ml 40 u ni t / ml of catalase of the above potassium phosphate buffer 5 ml 2 mM nitroblue tetrazolium above potassium phosphate buffer 5 ml 1.8 mM xanthine 17 ml 160 ml of the above potassium phosphate buffer 2.4 ml of the mixture of the above reagents, the lyophilized product of the extract of the above Preparation Example 1 or 2 dissolved in ethanol, water was added, and then ethanol was removed with an evaporator. 0.3 ml of a liquid (sample) adjusted to 0.1% by weight (dry matter) / volume%
In addition, xanthine oxidase (sample is water in advance,
When performing the experiment, adjust the above-mentioned potassium phosphate buffer so that the absorbance increases by about 0.02 per minute.)
Add 0.3 ml of the solution and immediately measure the absorbance (560 nm). (Measurement is divided into two to confirm linearity.) (Calculation formula) Inhibition rate = (AB) / A × 100 A: Change in absorbance per minute when water is used as a sample B: Sample Table 2 shows the result of conversion of the absorbance per minute into the 50% inhibitory concentration. However,
The final concentration is 1/9 of the concentration in this table .
【0020】[0020]
【表2】 [Table 2]
【0021】(使用テスト)女性12名づつの顔面を左
右に分け、一方を実施例、もう一方を比較例として毎
日、1回以上使用してもらって、3月後、アンケートし
た。実施例、比較例それぞれ1と2を併用した。判定基
準は以下のようでアンケートの結果をまとめたのが以下
の表である。 実施例の方が非常によい 3 実施例の方がかなりよい 2 実施例の方がややよい 1 差がない 0 比較例の方がややよい −1 比較例の方がかなりよい −2 比較例の方が非常によい −3 判定点の合計値を結果として表3に示す。(Usage Test) The face of each of 12 women was divided into left and right, one of which was used as an example and the other was used as a comparative example. Examples and Comparative Examples 1 and 2 were used in combination. The following table summarizes the results of the questionnaire with the following criteria. Example is very good 3 Example is considerably better 2 Example is slightly better 1 No difference 0 Comparative example is slightly better -1 Comparative example is much better -2 Comparative example Table 3 shows the total value of the -3 judgment points as a result.
【0022】[0022]
【表3】 [Table 3]
【0023】[0023]
【発明の効果】本発明の美白及び老化防止化粧料は仙鶴
草抽出物を含むことによって、皮膚に対し美白作用があ
り、活性酸素抑制効果があって皮膚の老化を防ぎ、小皺
や肌荒を防ぎ、しっとり感を増す効果がある。生薬とし
て使用されてきているので安全性については保証されて
いる。EFFECT OF THE INVENTION The whitening and anti-aging cosmetic composition of the present invention has a whitening effect on the skin, has an active oxygen suppressing effect, prevents aging of the skin, and suppresses fine wrinkles and rough skin by containing the extract of Senkaku grass. It has the effect of preventing and increasing the moist feeling. Since it has been used as a crude drug, its safety is guaranteed.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 下村 健次 三重県伊勢市船江3−16−32 (72)発明者 中村 雅美 三重県鳥羽市池上町6−32 (56)参考文献 特開 昭57−209208(JP,A) (58)調査した分野(Int.Cl.6,DB名) A61K 7/48 A61K 7/00──────────────────────────────────────────────────続 き Continuation of the front page (72) Inventor Kenji Shimomura 3-16-32 Funae, Ise City, Mie Prefecture (72) Inventor Masami Nakamura 6-32, Ikegami-cho, Toba City, Mie Prefecture (56) References JP-A-57- 209208 (JP, A) (58) Fields investigated (Int. Cl. 6 , DB name) A61K 7/48 A61K 7/00
Claims (1)
ル、メタノール、ブタノール、アセトン及びこれらの混
合物から選んだ少なくとも一種の溶媒で抽出した抽出物
を含む美白及び老化防止化粧料。1. A plant belonging to the genus Rosewood, Echinacea
Water, methanol, butanol, acetone and mixtures thereof
Extract extracted with at least one solvent selected from the compounds
And whitening and anti-aging cosmetics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3197490A JP2774882B2 (en) | 1991-07-12 | 1991-07-12 | Whitening and anti-aging cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3197490A JP2774882B2 (en) | 1991-07-12 | 1991-07-12 | Whitening and anti-aging cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0597648A JPH0597648A (en) | 1993-04-20 |
JP2774882B2 true JP2774882B2 (en) | 1998-07-09 |
Family
ID=16375340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3197490A Expired - Fee Related JP2774882B2 (en) | 1991-07-12 | 1991-07-12 | Whitening and anti-aging cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2774882B2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0616530A (en) * | 1992-07-03 | 1994-01-25 | Mikimoto Pharmaceut Co Ltd | Cosmetic |
JPH0680553A (en) * | 1992-09-03 | 1994-03-22 | Mikimoto Pharmaceut Co Ltd | Hyaluronidase inhibitor |
JP3519191B2 (en) * | 1995-12-15 | 2004-04-12 | 花王株式会社 | External preparation for skin |
JP5970148B2 (en) * | 2008-09-12 | 2016-08-17 | 丸善製薬株式会社 | Tyrosinase activity inhibitor, melanin production inhibitor, and SCF mRNA expression inhibitor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU83173A1 (en) * | 1981-02-27 | 1981-06-05 | Oreal | NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING POWDER RESULTING FROM THE SPRAYING OF AT LEAST ONE PLANT AND A COHESION AGENT |
-
1991
- 1991-07-12 JP JP3197490A patent/JP2774882B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0597648A (en) | 1993-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102253095B1 (en) | Cosmetic composition for improving acned skin, Manufacturing method thereof and functional cosmetics for improving acned skin containing the same | |
JPH06227960A (en) | Melanin formation inhibitor and skin cosmetic | |
JP3502415B2 (en) | Maillard reaction inhibitor | |
JP2006111545A (en) | Glutathione reductase activity-enhancing agent | |
JP4489923B2 (en) | Topical skin preparation | |
KR100994987B1 (en) | Cosmetic composition having skin soothing effect | |
JP2909825B2 (en) | Cosmetics | |
JP2774882B2 (en) | Whitening and anti-aging cosmetics | |
KR102415369B1 (en) | Functional bath cleanser composition comprising plant powder | |
JP2000256176A (en) | Skin cosmetic | |
JP2600036B2 (en) | Cosmetics | |
JP4413387B2 (en) | Collagen production promoter, elastase activity inhibitor, collagenase activity inhibitor and skin cosmetic | |
JPH0899891A (en) | Skin external agent | |
JP2690421B2 (en) | Cosmetics | |
JPH0892053A (en) | External preparation for skin | |
JP2778855B2 (en) | Cosmetics | |
JPH07258063A (en) | External preparation for skin | |
JPH07126143A (en) | Cosmetic | |
JPH05345705A (en) | Skin-beautifying cosmetic composition | |
JP3113009B2 (en) | Whitening cosmetics | |
JP2000256175A (en) | Cosmetic composition | |
JPH0597653A (en) | Cosmetic | |
JP2000212058A (en) | Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor | |
JP2003267882A (en) | Skin cosmetic | |
JP3547155B2 (en) | Active oxygen suppressant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313115 |
|
S631 | Written request for registration of reclamation of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313631 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |